Iwase H - Search Results

1

Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor.

Yamamoto Y, Masuda N, Ohtake T, Yamashita H, Saji S, Kimijima I, Kasahara Y, Ishikawa T, Sawaki M, Hozumi Y, Iwase H. Yamamoto Y, et al. Among authors: iwase h. Breast Cancer. 2010 Oct;17(4):254-60. doi: 10.1007/s12282-009-0148-2. Epub 2009 Aug 15. Breast Cancer. 2010. PMID: 19685269

2

[Experience of high-dose toremifene treatment for postmenopausal women with metastatic breast cancer].

Yamamoto Y, Kawazoe T, Iwase H. Yamamoto Y, et al. Among authors: iwase h. Gan To Kagaku Ryoho. 2005 Oct;32(10):1415-9. Gan To Kagaku Ryoho. 2005. PMID: 16227740 Japanese.

3

Pathological lymph node involvement at surgery is a significant predictive factor of recurrence in locally advanced breast cancer treated with concomitant epirubicin-docetaxel neoadjuvant chemotherapy: a cohort study.

Kai K, Arima N, Miyayama H, Yamamoto Y, Iwase H, Nishimura R. Kai K, et al. Among authors: iwase h. Breast Cancer. 2009;16(1):42-8. doi: 10.1007/s12282-008-0055-y. Epub 2008 May 27. Breast Cancer. 2009. PMID: 18504642

4

Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer.

Yamamoto Y, Iwase H. Yamamoto Y, et al. Among authors: iwase h. Int J Clin Oncol. 2008 Oct;13(5):384-94. doi: 10.1007/s10147-008-0828-5. Epub 2008 Oct 23. Int J Clin Oncol. 2008. PMID: 18946748 Review.

5

Clinicopathological features and treatment strategy for triple-negative breast cancer.

Yamamoto Y, Iwase H. Yamamoto Y, et al. Among authors: iwase h. Int J Clin Oncol. 2010 Aug;15(4):341-51. doi: 10.1007/s10147-010-0106-1. Epub 2010 Jul 15. Int J Clin Oncol. 2010. PMID: 20632057 Free article.

6

A randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-months depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer.

Shiba E, Yamashita H, Kurebayashi J, Noguchi S, Iwase H, Ohashi Y, Sasai K, Fujimoto T. Shiba E, et al. Among authors: iwase h. Breast Cancer. 2016 May;23(3):499-509. doi: 10.1007/s12282-015-0593-z. Epub 2015 Feb 6. Breast Cancer. 2016. PMID: 25655898 Free PMC article. Clinical Trial.

7

Clinical benefit of sequential use of endocrine therapies for metastatic breast cancer.

Iwase H, Yamamoto Y. Iwase H, et al. Int J Clin Oncol. 2015 Apr;20(2):253-61. doi: 10.1007/s10147-015-0793-8. Epub 2015 Feb 12. Int J Clin Oncol. 2015. PMID: 25673474 Review.

8

Semi-quantitative immunohistochemical analysis of aromatase expression in ductal carcinoma in situ of the breast.

Zhang Z, Yamashita H, Toyama T, Hara Y, Omoto Y, Sugiura H, Kobayashi S, Harada N, Iwase H. Zhang Z, et al. Among authors: iwase h. Breast Cancer Res Treat. 2002 Jul;74(1):47-53. doi: 10.1023/a:1016022314608. Breast Cancer Res Treat. 2002. PMID: 12150452

9

The role of Stat5 in estrogen receptor-positive breast cancer.

Yamashita H, Iwase H. Yamashita H, et al. Among authors: iwase h. Breast Cancer. 2002;9(4):312-8. doi: 10.1007/BF02967610. Breast Cancer. 2002. PMID: 12459712

10

Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast.

Zhang Z, Yamashita H, Toyama T, Omoto Y, Sugiura H, Hara Y, Wu X, Kobayashi S, Iwase H. Zhang Z, et al. Among authors: iwase h. Breast Cancer Res. 2003;5(6):R250-6. doi: 10.1186/bcr657. Epub 2003 Oct 9. Breast Cancer Res. 2003. PMID: 14580261 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

914 results

Search Page

Filters